Neumora Therapeutics (NMRA) Accumulated Expenses (2022 - 2026)
Neumora Therapeutics (NMRA) recorded Accumulated Expenses of $23.33 million in Q2 2026, up 15.2% from $20.25 million a year earlier but down 5.8% from the prior quarter.
Powered by 
Analysis
Neumora Therapeutics (NMRA) Accumulated Expenses (2022 - 2026) Analysis & Trends
At the end of FY2025, Neumora Therapeutics reported Accumulated Expenses of $28.79 million, up 17.1% from FY2024.
- Annual Accumulated Expenses has increased for three straight years, with a three-year compound annual growth rate of 35.6% (FY2022 to FY2025).
- Across earlier years, Accumulated Expenses came in at $24.59 million in FY2024 (+15.7%), $21.26 million in FY2023 (+84.3%) and $11.54 million in FY2022.
- Quarterly Accumulated Expenses has ranged from $11.54 million in Q4 2022 to $28.79 million in Q4 2025 over the past five years.
- On a year-over-year basis, Accumulated Expenses rose in six of the last eight quarters, with growth averaging 11.9%.
- Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 84.3% in Q4 2023, against a decline of 5.7% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $24.77 million (Q1 2026), $28.79 million (Q4 2025) and $24.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Neumora Therapeutics | 78.88 Mn | -539.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.33 Mn |
| Mar 31, 2026 | 24.77 Mn |
| Dec 31, 2025 | 28.79 Mn |
| Sep 30, 2025 | 24.98 Mn |
| Jun 30, 2025 | 20.25 Mn |
| Mar 31, 2025 | 26.27 Mn |
| Dec 31, 2024 | 24.59 Mn |
| Sep 30, 2024 | 22.76 Mn |
| Jun 30, 2024 | 18.30 Mn |
| Mar 31, 2024 | 19.49 Mn |
| Dec 31, 2023 | 21.26 Mn |
| Sep 30, 2023 | 23.35 Mn |
| Dec 31, 2022 | 11.54 Mn |
API Access
Neumora Therapeutics Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "NMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();